A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPARα and PCK1
5:2 间歇性禁食方案可通过肝脏 PPARα 和 PCK1 改善 NASH 和纤维化并延缓 HCC 发展
期刊:Cell Metabolism
影响因子:27.7
doi:10.1016/j.cmet.2024.04.015
Suchira Gallage, Adnan Ali, Jose Efren Barragan Avila, Nogayhan Seymen, Pierluigi Ramadori, Vera Joerke, Laimdota Zizmare, David Aicher, Indresh K Gopalsamy, Winnie Fong, Jan Kosla, Enrico Focaccia, Xin Li, Suhail Yousuf, Tjeerd Sijmonsma, Mohammad Rahbari, Katharina S Kommoss, Adrian Billeter, Sand